Table 2 Association of HNF1B expression and clinicopathological characteristics, based on 93 cases of ccRCC.
From: Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours
Characteristic | Group | N | H-score mean | H-score median | p-valuea | Categorized H-score | |||
---|---|---|---|---|---|---|---|---|---|
Group 1 | Group 2 | Group 3 | p-valueb | ||||||
Gender | 0.617 | 0.399 | |||||||
Male | 54 | 198.2 | 240 | 12 | 13 | 29 | |||
Female | 39 | 205.8 | 250 | 10 | 5 | 24 | |||
Age (mean = 63, median = 65) | 0.849 | 0.414 | |||||||
˂ 65 | 44 | 198.9 | 240 | 8 | 8 | 28 | |||
≥ 65 | 49 | 203.5 | 260 | 14 | 10 | 25 | |||
pT classification | 0.094 | 0.360 | |||||||
pT1 | 70 | 212.4 | 265 | 15 | 11 | 44 | |||
pT2 | 6 | 141.7 | 145 | 2 | 2 | 2 | |||
pT3 | 17 | 177.1 | 170 | 5 | 5 | 7 | |||
Grade | 0.002 | 0.012 | |||||||
G1 | 22 | 255.5 | 300 | 2 | 2 | 18 | |||
G2 | 53 | 196.1 | 240 | 14 | 9 | 30 | |||
G3 | 13 | 167.7 | 170 | 3 | 6 | 4 | |||
G4 | 5 | 106.0 | 50 | 3 | 1 | 1 | |||
Lymphovascular invasion* | 0.264 | 0.558 | |||||||
Yes | 15 | 177.3 | 200 | 5 | 3 | 7 | |||
No | 75 | 207.1 | 260 | 16 | 14 | 45 | |||
Metastasis* | 0.121 | 0.135 | |||||||
Yes | 10 | 158.0 | 140 | 3 | 4 | 3 | |||
No | 81 | 207.8 | 250 | 18 | 14 | 49 | |||
Recurrence* | 0.458 | 0.899 | |||||||
Yes | 8 | 183.8 | 210 | 2 | 2 | 4 | |||
No | 83 | 204.1 | 250 | 19 | 16 | 48 | |||
rs4430796* | 0.727 | 0.951 | |||||||
Yes | 31 | 207.7 | 270 | 6 | 2 | 21 | |||
No | 8 | 276.3 | 295 | 0 | 1 | 5 | |||
rs757210* | 0.384 | 0.528 | |||||||
Yes | 36 | 216.1 | 275 | 0 | 0 | 3 | |||
No | 3 | 290.0 | 290 | 6 | 3 | 23 |